Product Information
FLUTICASONE PROP 0.005% OINT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.5415 per GM under NDC 45802022135. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 14, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.05 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802022135
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
FLUTICASONE PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA076668FDA Approved
5/14/2004
TE Code
AB
On Market Since
7/9/2007
Pharmacological Classes
Price Statistics
The NADAC for FLUTICASONE PROP 0.005% OINT has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 36.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5415 per GM |
|---|---|
| All-time high | $0.6764 (Aug 13, 2025) |
| All-time low | $0.2916 (Oct 21, 2015) |
| 52-week high | $0.6419 |
| 52-week low | $0.5415 |
| Median price | $0.5056 |
| Average price | $0.5094 |
| Largest weekly change | +74.3% (Dec 23, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluticasone Propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUTICASONE PROP 0.005% OINT?
The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE PROP 0.005% OINT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.5415 per GM (NDC 45802022135), effective Sep 30, 2026.
How has the price of FLUTICASONE PROP 0.005% OINT changed over time?
Over the history we have for it, the NADAC for FLUTICASONE PROP 0.005% OINT has risen 36.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLUTICASONE PROP 0.005% OINT?
Since Nov 28, 2013, the NADAC for FLUTICASONE PROP 0.005% OINT has ranged from a low of $0.2916 (Oct 21, 2015) to a high of $0.6764 (Aug 13, 2025), with a median of $0.5056 per GM.
Are there cheaper alternatives to FLUTICASONE PROP 0.005% OINT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUTICASONE PROP 0.005% OINT, is $0.3648 per GM — about 33% below FLUTICASONE PROP 0.005% OINT.
Who manufactures FLUTICASONE PROP 0.005% OINT?
FLUTICASONE PROP 0.005% OINT (NDC 45802022135) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.